Epicure Therapeutics, Inc.
Seattle, WA
- UEI
- EVQMQE2B6Q48
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 615 Westlake Ave N, Seattle, WA 98109, USA
- Website
- epicuregtx.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Cell class-specific AAV gene therapy for SLC6A1-related neurodevelopmental disorder - project summary SLC6A1-related… | National Institute of Neurological Disorders and Stroke | $1,499,817 |
Quick answers
What is Epicure Therapeutics, Inc.'s UEI?
Epicure Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is EVQMQE2B6Q48.
Where is Epicure Therapeutics, Inc. located?
Epicure Therapeutics, Inc.'s physical address in SAM.gov is 615 Westlake Ave N, Seattle, WA 98109, USA.
Is Epicure Therapeutics, Inc. registered in SAM.gov?
Yes. Epicure Therapeutics, Inc.'s SAM.gov registration is active through February 12, 2027.
What is Epicure Therapeutics, Inc.'s most recent federal award?
Epicure Therapeutics, Inc.'s most recent federal grant award is Cell class-specific AAV gene therapy for SLC6A1-related neurodevelopmental disorder - project summary SLC6A1-related… (R44NS145930), from National Institute of Neurological Disorders and Stroke, on July 16, 2026.
On GovTribe
See Epicure Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors